Capping of comparator cohort patients
|
|
2
|
2453
|
April 29, 2022
|
Collider bias question
|
|
4
|
2759
|
April 21, 2022
|
RCT and "Mathematical Embellishment"
|
|
2
|
3592
|
April 5, 2022
|
Article: Going from evidence to recommendations: Can GRADE get us there?
|
|
0
|
2036
|
April 3, 2022
|
Estimate treatment effect in study with a composite complication score as outcome
|
|
9
|
2991
|
February 18, 2022
|
Single cluster cluster randomized crossover (CRXO) design?
|
|
3
|
2176
|
February 17, 2022
|
Bernoulli trials vs completely randomized trials
|
|
0
|
2545
|
January 5, 2022
|
Catastrophic Heterogeneity Meets "The Clairvoyant RCT"
|
|
0
|
2089
|
December 28, 2021
|
Nonparametric multiple linear regression (with interaction term and all !)
|
|
3
|
4160
|
December 18, 2021
|
Cost-effectiveness based interim analysis
|
|
2
|
2869
|
December 15, 2021
|
Scenarios to use GEE vs. GLM
|
|
3
|
6554
|
December 15, 2021
|
Delphi Method Consensus
|
|
0
|
2318
|
December 9, 2021
|
Validity of comparing two different previously published cohort studies using IPTW for matching
|
|
5
|
2712
|
November 11, 2021
|
Question about symmetry in dichotimization cutpoints in Federov et al. 2009
|
|
3
|
3068
|
October 1, 2021
|
Tools for assessing for equity
|
|
6
|
4132
|
September 20, 2021
|
Pre-testing two competing surveys with overlapping items
|
|
0
|
1872
|
September 3, 2021
|
How to update a prognostic model of COVID-19 for the effect of vaccination
|
|
3
|
2638
|
August 7, 2021
|
Prediction model with one very strong predictor and other predictors?
|
|
3
|
3267
|
August 5, 2021
|
Survey Non-Response Weighting Stata
|
|
11
|
10999
|
June 13, 2021
|
Default Using R package to implement Bayesian phase I/II dose-finding design for three outcomes
|
|
10
|
4122
|
June 10, 2021
|
Bootstrap and prior distribution method for self-controlled case series design
|
|
0
|
2305
|
June 9, 2021
|
Statistical conundrum: multiple noisy measurements vs an oracle
|
|
7
|
22669
|
May 24, 2021
|
Association of continuous outcomes with binary endpoints; and "optimal" cut-off points
|
|
3
|
2763
|
May 3, 2021
|
Provisions for outilers and strategies
|
|
2
|
3874
|
March 15, 2021
|
Advice on study design
|
|
6
|
4215
|
March 3, 2021
|
Early use of tocilizumab and steroids does not impact expansion or persistence of CAR T cells in B-ALL?
|
|
2
|
3853
|
February 17, 2021
|
Does removing other events from training data amount to data snooping?
|
|
4
|
3045
|
February 10, 2021
|
RCT trials for COVID study vaccines
|
|
0
|
3207
|
October 24, 2020
|
CAR T Cells - Major Challenges (Research Methods/Design, Treatment Comparison/Design)
|
|
0
|
2297
|
October 22, 2020
|
Bayesian solution for study designs
|
|
0
|
3251
|
September 24, 2020
|